Damona Pharmaceuticals receives FDA clearance to initiate Phase 1 clinical trial for innovative brain disorder treatment 11/6/2024 Category: PORTFOLIO NEWS
Angelini Ventures contributes to the new Angelini Industries ESG Strategy 2024-2026 11/6/2024 Category: SUSTAINABILITY
Lola Buono, Associate at Angelini Ventures, shares industry expertise on Radio 24's podcast 10/25/2024 Category: FEATURED IN
Biotech Insights: our Medical Director discusses healthcare strategies on BiotechTV 10/21/2024 Category: FEATURED IN
Cour Pharmaceuticals recognized as a top innovator in Fierce Biotech’s 2024 Fierce 15 8/28/2024 Category: FEATURED IN, PORTFOLIO NEWS
Angelini Ventures' parent company Angelini Industries reports significant growth in FY 2023 consolidated financial statements 7/19/2024 Category: FEATURED IN
Angelini Ventures